Shared Decision for Drug Interactions in Oral Anticoagulation

Running, not enrolling · Not applicable

Conditions studied: Anticoagulants, Drug Interactions

In brief

The purpose of this project is to implement and evaluate a shared-decision making (SDM) tool called DDInteract that was developed to support decision making for drug-drugs interactions while on oral anticoagulants. DDInteract will be implemented in clinics at the University of Utah, University of Colorado and University of Vanderbilt. DDInteract will be launched from within the electronic health record (EHR) retrieving patient-specific risk factors, will calculate the risk of harm, and will allow providers and patients to dynamically explore "what if" scenarios to optimize treatment and minimize risk. DDInteract will enable shared-decision making using individually-tailored information on the potential benefits and harms of drug interactions in anticoagulated patients.

Key facts

Study ID

NCT06401863

Run by

University of Utah

People needed

3691

Starts

2023-10-01

Expected to finish

2026-07-31

Last updated by the study team

2026-06-26

Who can join

Age: 21 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Be at least 21 years of age or older
• Receive more than one prescription of an oral anticoagulant (i.e. warfarin, apixaban, edoxaban, dabigatran, rivaroxaban)

You may not qualify if…

• Individuals not able to speak English or Spanish

Where it is running

• University of Colorado. School of Medicine — Denver, Colorado, United States
• Vanderbilt University — Nashville, Tennessee, United States
• University of Utah — Salt Lake City, Utah, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.